ReviewGenomics, proteomics & bioinformatics2025
Macrophages in Hematopoiesis and Related Blood Diseases.
Review in Genomics, proteomics & bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Emerging evidence indicates that macrophages play important roles in hematopoiesis in addition to their immune functions. The well-known immune-unrelated functions of macrophages include their roles in hematopoiesis, especially the quality control of hematopoietic stem cells (HSCs) and hematopoietic stem and progenitor cells (HSPCs), the support of erythropoiesis, and the regulation of megakaryopoiesis. Several studies, most using mouse models, have explored the roles of macrophages in hematopoiesis in different organs such as the yolk sac (YS), fetal liver (FL), bone marrow (BM), and spleen (SP). We have recently documented the potential roles and underlying mechanisms of macrophages in myeloproliferative neoplasm (MPN), aplastic anemia (AA), and idiopathic thrombocytopenic purpura (ITP). In this article, we review the origin of macrophages, introduce their roles in regulating HSCs/HSPCs, erythropoiesis, and megakaryopoiesis within four hematopoietic organs, and summarize the recent advances of macrophages in MPN, AA, and ITP. Finally, we outline the unresolved questions that future studies should address to explore in greater depth the role of macrophages in both normal and disordered hematopoiesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.